Thrombo inCode has been presented during the Asebio session about “New technologies based in Haematology biomarkers”
Madrid, 2013/03/19
The session organized by Asebio (Spanish Association Companies) has been an opportunity for collaboration between biotechnology sector and the Spanish Health System. In this forum, Eduardo Salas, scientific director of Gendiag, has presented the new development Thrombo inCode, diagnostic product that integrates and automates the detection of 12 genetic factors of risk associated to thromboembolism and that improves the preventive strategy in patients and relatives with risk to suffering thromboembolic events.
